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Abstract 
Diabetes mellitus has a major impact on the metabolic activity of a significant number of tissues. Its impact on 
the jaw bones cannot be neglected, especially if rehabilitation using prosthetic restorations supported on dental 
implants is intended. The aim of this study is to comparatively analyze vascularization, the degree of 
mineralization and the cellular component of the mandible in type 2 diabetes mellitus patients undergoing dental 
implant placement. For this study, eight patients assigned to two groups were selected. The study group included 
four patients with type 2 diabetes mellitus in whom dental implants were placed, and the control group 
comprised 4 patients without systemic pathology. The bone debris obtained after dental implant placement were 
collected and analyzed using hematoxylin-eosin and PAS–Alcian Blue staining. The results obtained indicated 
the presence of diabetic angiopathy in the mandible, a higher cellular density in the diabetic bone, and a lower 
degree of mineralization in the bone taken from patients of the study group. In conclusion, histological changes 
can be detected in the mandible of patients with type 2 diabetes mellitus compared to those without systemic 
disease, but their effect on bone healing cannot be quantified. 
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1. Introduction  
Type 2 diabetes mellitus (T2DM) is a major metabolic disorder with impact on many human tissues, including 
the jaw bones. Its effect on the quality of bone is still a debated subject in the literature. Some authors maintain 
that patients with diabetes mellitus (DM) have a more fragile bone structure [1, 2], regardless of the type of 
diabetes, while other authors indicate an increase in bone density in patients with T2DM [3, 4]. Paradoxically, 
an increase in the degree of bone mineralization is observed in T2DM patients [1, 2, 4], which suggests that 
diabetic patients present a deficiency of the non-mineral component that might reduce bone quality. The role of 
bone status in patients with T2DM becomes increasingly important in the case of oral function rehabilitation, 
because one of the best rehabilitation methods uses prosthetic restorations supported on endosseous dental 
implants [5]. Some authors have identified a lower rate of osseointegration in patients with T2DM compared to 
non-diabetic patients, with a rate of failure ranging between 4% and 14% [5, 6]. However, dental implant 
rehabilitation remains without any doubt a very good method for the restoration of oral cavity functions in 
T2DM patients, but an improvement in the success rate of dental implant osseointegration is required. The aim 
of this study is to evaluate jaw bone quality in patients with T2DM in order to determine their characteristics. In 
this way, the elements directly involved in dental implant osseointegration can be identified.  
2. Material and method 
For the current study, four patients were selected from the authors’ clinical patients, who required treatment of 
missing teeth using dental implants. The patients were selected in the period December 2015 – August 2016. In 
parallel, the same number of patients were recruited in the control group. The study inclusion criteria were: adult 
patient, patient with mandibular missing teeth, patient with type 2 diabetes mellitus, absence of other systemic 
diseases or drug therapies altering bone metabolism, patient having signed an informed consent for participation 
in the study. The control group was selected to match the general characteristics of the patients in the study 
group, the only difference between the two groups being the presence or absence of T2DM. Biological samples 
were collected from the bone debris obtained at the time of dental implant placement. The resulting bone debris 
were introduced in containers with formol and sent for histological evaluation. The variables monitored for each 
histological sample were the following: presence/absence of angiopathy in the bone structure, bone cellularity 
(of three degrees, high, moderate and low), and bone mineralization (low, moderate and high). Histological 
analysis was performed in eight samples, four for each group. The histological protocol was as follows: fixation 
of the samples in formol for at least 24 hours, washing of the samples with water and their immersion in 
trichloroacetic acid until the tissue samples were soaked, washing of the samples followed by their treatment 
with sodium sulfate aqueous solution. The next stage was dehydration using three alcohol solutions of different 
concentrations (70
° 
alcohol, 90
° 
alcohol, absolute alcohol). The third stage was decalcification in xylene bath 
solution, followed by paraffin embedding. The samples were cut with the microtome in sections between 3 and 
5 microns. Using a float bath, the samples were displayed on glass slides. Subsequently, the sections were 
deparaffinized and rehydrated for staining. Hematoxylin-eosin staining was used according to the following 
protocol: immersion of the sections in distilled water, hematoxylin staining of the nuclei (5 minutes), 
differentiation with 0.3% acid alcohol, washing with tap water, eosin staining (2 minutes), dehydration, 
clarification. Subsequently, the tissues were mounted between two microscope slides. Concomitantly, PAS-
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Alcian Blue staining was used as follows: deparaffinization, immersion in distilled water, Alcian Blue staining 
(15 minutes), washing with tap water (2 minutes), washing with distilled water, Schiff reagent staining (10 
minutes), energetic washing with tap water (5 minutes), hematoxylin staining of the nuclei (1 minute), acid 
alcohol differentiation, washing with Scott solution, dehydration, clarification, mounting.  Images were captured 
using an HD camera attached to a Leica DM 300 microscope and were processed with the software provided by 
the manufacturer.  The results were centralized using Microsoft Excel. 
3. Results  
Diabetic microangiopathy was evidenced in 3 of the 4 samples taken from patients of the T2DM group. The 
angiosclerosis appearance is specific to patients with T2DM in PAS-Alcian Blue staining, where acid 
glycoproteins stain blue, neutral glycoproteins stain purple and cellular nuclei stain blue (Figure 1). 
 
Figure 1: Diabetic angiosclerosis appearance. PAS-Alcian-Blue 100X. In the connective vascular tissue, small 
size blood vessels can be seen, which show homogeneous amorphous material deposits (PAS+). Thickened 
basal membrane. 
Differences between the two groups also occurred when analyzing bone cellularity. Thus, in the case of the 
T2DM group, different degrees of cellularity were observed, two patients showed increased cellularity (Figure 
2), one patient exhibited moderate bone cellularity (Figure 3), and one patient had low cellularity (Figure 4). 
Unlike the study group, all patients in the control group presented low cellularity. 
 
Figure 2: Highly cellular connective vascular tissue and cartilaginous tissue. HE 200X 
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Figure 3: Bone tissue with moderate cellularity. HE 100X 
 
Figure 4: Bone tissue with low cellularity. HE100X 
Bone mineralization was low for three patients (Figure 5) in the T2DM group and moderate in the case of one 
patient, while in the control group, a high degree of mineralization was observed for all 4 patients (Figure 6). 
 
Figure 5: Low mineralization bone tissue slides. Low cellularity. HE100X 
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Figure 6: High mineralization compact bone tissue slides. HE 200X 
4. Discussions  
The histological results obtained evidenced significant differences between the bone of diabetic and non-
diabetic patients. The mandible is affected by diabetic angiopathy similarly to the rest of human tissues. This is 
not surprising considering the multitude of tissues affected by this complication of T2DM [7]. However, some 
authors maintain that the impact of angiopathy on dental implant osseointegration is not major, which is proved 
by the high success rate of implant-prosthetic rehabilitation in patients with T2DM [1, 2, 8]. Most probably, 
angiosclerosis explains the frequent development of periodontal disease in T2DM patients [9, 10] and possibly, 
in the peri-implant areas. One of the main limitations presented by this study is the relatively small number of 
biological samples that can statistically confirm angiosclerosis in the maxillary bones of patients with T2DM. 
To clarify this problem, a prospective study in a larger group of patients is required; the data obtained in the 
current study are not sufficient to validate this hypothesis. Surprisingly, the degree of bone cellularity in patients 
with T2DM is high, which indicates a good postoperative healing potential [11]. The increase in cellularity does 
not mean an adequate metabolic activity of bone cells. Thus, as evidenced by a series of literature studies, the 
development of metabolic angiopathy is associated with an impairment of cellular functions in tissues such as 
retinal or brain tissue [12, 13]. This can explain why, despite the increased cellularity present in the bone of 
diabetic compared to non-diabetic patients, bone healing outcomes are not so good. A limitation of the current 
study is the fact that bone cellularity was evaluated without evaluating the type of cells present at the bone level. 
A more accurate histological evaluation of the type of cells present in the alveolar bone of the patient with 
T2DM is required to determine their main activity. Increased cellular density in the samples of T2DM patients is 
inversely proportional to the degree of bone mineralization in patients of the study group. The results obtained 
indicate a significant diminution of the mineral component in patients with T2DM; only one patient had 
moderate bone mineralization. This diminution of the mineral component was confirmed by imaging studies 
[14] as well as in vitro experimental studies [3]. The results obtained by us in this regard are relatively clear, 
while the subject is extensively debated in the literature. Some authors show an association between diminished 
bone mineralization, a reduced cell division rate and the alteration of the collagen matrix in patients with T2DM 
[3]. On the other hand, there are authors who maintain that a metabolic acceleration and increased remodeling 
occur in the bone [15]. It is quite difficult for us to support the second variant, especially when considering that 
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there is a lower rate of bone osseointegration and implicitly of bone healing in patients with T2DM, even if the 
difference is not statistically significant. Recent studies show a diminution of the bone healing rate in the 
context of T2DM, without this contraindicating implant-prosthetic rehabilitation in diabetic patients [16, 17].  
The results obtained in this pilot study evidence the need for further research in order to determine the degree of 
metabolic activity in the jaw bones of T2DM patients. 
5. Conclusion 
The presence of T2DM has an obvious impact on the structure of the jaw bones in which dental implant 
placement is intended, without influencing their implant osseointegration capacity. 
6. Recommendations 
Data obtained so far indicate that dental implants can be used in patients with T2DM with a good prognosis. 
Compliance with the standard protocol for insertion and prosthesis of dental implants in the patient with T2DM 
seems to be sufficient for having a favorable postoperative evolution. 
References 
[1] Thomas WO, Guy H-B, Vargas A, Alexander P, Feine J, Critical Review of Diabetes, Glycemic Control 
and Dental Implant Therapy Clin Oral Implants Res, vol. 24, nr.2, pp. 117-127,   Feb 2013  
[2] Thomas W. Oates Jr, Patrick Galloway, Peggy Alexander, Adriana Vargas Green, Guy Huynh-Ba, Jocelyn 
Feine, C. Alex McMahan. The effects of elevated hemoglobin A1c in patients with type 2 diabetes 
mellitus on dental implants. Survival and stability at one year. JADA, vol. 145, nr.12, pp.1218-1226,  
2014  
[3] Yamauchi M. Assessment of bone quality in lifestyle-related diseases. Clin Calcium, vol. 26, nr.1, pp. 65-
72, Jan 2016 
[4] Piscitelli P, Neglia C, Vigilanza A, Colao A. Diabetes and bone: biological and environmental factors. 
Curr Opin Endocrinol Diabetes Obes., vol. 22, nr.6, pp. 439-445, Dec 2015 
[5] Maureen Rcourtney, Edward J Moler, John Aosborne. Geoff Whitney. Scott Econard. Diabetes, Metabolic 
Syndrome and Obesity: Targets and Therapy, vol 8, pp. 447-453, 2015 
[6] Juncar RI, Juncar M, Onişor-Gligor F, Popa AR. Effect of masticatory forces transmitted by dental 
implants on the mandibular bone of patients with type 2 diabetes mellitus. Rom J Diabetes Nutr Metab 
Dis., vol. 22, nr. 4, pp.419-424, 2017 
[7] Anthony S. Fauci et al. Harrison’s principles of internal medicine. 17th ed. New York: McGraw Hill, 
Health Professions Division; 2008. 
American Scientific Research Journal for Engineering, Technology, and Sciences (ASRJETS) (2019) Volume 61, No  1, pp 54-60 
60 
 
[8] Juncar RI, Juncar M, Onişor-Gligor F, Popa AR. Effect of masticatory forces transmitted by dental 
implants on the mandibular bone of patients with type 2 diabetes mellitus. Rom J Diabetes Nutr Metab 
Dis., vol. 22, nr. 4, pp.419-424, 2017 
 [9] Navarro-Sanchez AB, Faria-Almeida R, Bascones-Martinez A. Effect of non-surgical periodontal therapy 
on clinical and immunological response and glycaemic control in type 2 diabetic patients with 
moderate periodontitis. J Clin Periodontol., vol.34, nr. 10, pp.835-843, 2007 
[10] Jimenez  M, Hu FB, Marino M, Yi Li,  Joshipura KJ. Type 2 diabetes mellitus and 20 year incidence of 
periodontitis and tooth loss. Diabetes Research and Clinical Practice, vol.98, pp.494-500, 2012 
[11] Zhou W, Tangl S, Reich KM, Kirchweger F, Liu Z, Zechner W, Ulm C, Rausch-Fan X. The Influence of 
Type 2 Diabetes Mellitus on the Osseointegration of Titanium Implants With Different Surface 
Modifications-A Histomorphometric Study in High-Fat Diet/Low-Dose Streptozotocin-Treated Rats. 
Implant Dent., vol.28, nr.1, pp.11-19, Feb 2019  
[12] Yang Y, Zeng C, Lu X, Song Y, Nie J, Ran R, Zhang Z, He C, Zhang W, Liu SM 5-
Hydroxymethylcytosines in Circulating Cell-Free DNA Reveal Vascular Complications of Type 2 
Diabetes. Clin Chem., Oct 2019  
[13] Hayden MR. Type 2 Diabetes Mellitus Increases The Risk of Late-Onset Alzheimer's Disease: 
Ultrastructural Remodeling of the Neurovascular Unit and Diabetic Gliopathy. Brain Sci., vol. 9, nr.10, 
pp. 262, Sep 2019  
[14] Piscitelli P, Neglia C, Vigilanza A, Colao A. Diabetes and bone: biological and environmental factors. 
Curr Opin Endocrinol Diabetes Obes., vol.22, nr. 6, pp.439-445, Dec 2015 
[15] Bilezikian JP, Watts NB, Usiskin K, Polidori D, Fung A, Sullivan D, Rosenthal N. Evaluation of Bone 
Mineral Density and Bone Biomarkers in Patients With Type 2 Diabetes Treated With Canagliflozin. J 
Clin Endocrinol Metab., vol.101, nr.1, pp.44-51, Jan 2016  
[16] de Oliveira-Neto OB, Santos IO, Barbosa FT, de Sousa-Rodrigues CF, de Lima FJ. Quality assessment 
of systematic reviews regarding dental implant placement on diabetic patients: an overview of 
systematic reviews. Med Oral Patol Oral Cir Bucal., vol.24, nr.4, pp.483-490, Jul 2019 
[17] Sundar G, Sridharan S, Sundaram RR, Prabhu S, Rao R, Rudresh V. Impact of well-controlled type 2 
diabetes mellitus on implant stability and bone biomarkers. Int J Oral Maxillofac Implants., Jun 201 
 
 
